Five significantly upregulated biomarkers (SPC25, NUF2, MCM2, BLM, and AURKA) were found to predict survival risk in HCC patients, and a risk score model was established. The patients with higher risk scores had the worse survival compared with lower ones. The gene discussed is BLM; the disease is hepatocellular carcinoma.